With a valuation of US$ XX Mn in 2016 which is expected to reach US$ XX Mn by 2022 and a Compounded Annual Growth rate of XX%, the Global Injectables Drug-delivery devices Market is increasing at a steady pace. This kind of drug delivery allows for maximum bioavailability as it bypasses the first pass metabolism. The devices that are used are highly customised to suit the personal needs of each customerMarket Dynamics
The factors that drive growth for the Injectables Drug-delivery devices Market include increasing cases of chronic diseases like cancer. The health issues that may arise from the use of needles is a major challenge for this industry. Another challenge for this industry is the regulatory uncertainties.
The market also throws up several opportunities with regard to a large number of technological developments.Market Segmentation
The market is segmented in terms of the type, mode of delivery, therapeutic use, and geography.
In terms of the product type, the market is classified into self-injection type and conventional injection type.
In terms of mode of delivery, the market is segmented into nasal, oral, ocular, injectable, transdermal and topical.
The different geographic market segments are North America, Europe, Asia Pacific and Rest of the world.
North America is the dominating market in terms of market share due to the greater awareness and high incomes. North America is followed by Europe in terms of market share. But in terms of growth rate, Asia Pacific is the expected to be the leader because of the increasing awareness amongst the public and the developing infrastructureKey Players
Some of the major players in the market include Polymer Factory, Alkermes Inc., Pearl Therapeutics Inc, QLT Inc, UCB Group, Bend Research, BIND Biosciences, Inc.
The report contains comprehensive analysis on:
Global Injectables Drug-delivery devices Market Segments
Global Injectables Drug-delivery devices Market Drivers, Restraints and Opportunities
Global Injectables Drug-delivery devices Market Size & Forecast 2016 to 2022
Supply & Demand Value Chain
Global Injectables Drug-delivery devices Market Current Trends
Competition & Major Companies Technology
and R&D Status
Porters Five Force Analysis
Strategic and Critical Success Factor Analysis of Key Players
Regional analysis for Global Injectables Drug-delivery devices Market includes
--> North America
>> US and Canada
--> Latin America
>> Mexico, Brazil, Argentina and Rest of Latin America
--> Western Europe
>> EU5 (Germany, France, Italy, Spain, U.K.)
>> Nordic Countries (Denmark, Finland, Norway, and Sweden)
>> Benelux (Belgium, The Netherlands, and Luxembourg)
>> Rest of Western Europe
--> Eastern Europe
>> Rest of Eastern Europe
--> Asia Pacific
>> Australia and New Zealand
>> Rest of Asia Pacific
--> Middle East and Africa
>> GCC countries (Saudi Arabia, Oman, Qatar, Bahrain, UAE and Kuwait)
>> South Africa
>> North Africa
>> Rest of Middle East and Africa
This report is an elaborate aggregation of primary inputs from industry experts and participants across the supply chain. It provides in-depth market segmentation that is derived from extensive product mapping exercises, macro-economic factors and other qualitative and quantitative insights. The impact of all such factors are delivered across multiple market segments and geographies. Report Highlights:
-->Detailed Historical Overview (Market Origins, Product Launch Timeline, etc.)
-->Consumer and Pricing Analysis
--> Market dynamics of the industry
-->In-depth Market Segmentation
-->Historical and Projected Market Sizing in terms of volume and value
-->Recent market trends and Impact Factors
-->R&D Status and Technology
-->Extensive Industry Structure Coverage
Publisher Name : Market Litmus